4 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 4, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Female Sexual Dysfunction: new trials by email Literature Review of Female Sexual Dysfunction trials Research Report on Female Sexual Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Female Sexual Dysfunction Assessment and Managment of Vaginismus Botox, Radiofrequency - Female Sexual Dysfunction | Phase 2 / Phase 3 | Not yet recruiting | Assiut University | 40 | 2025-01-01 | 2025-01-01 |
| Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder BZ371A 7.5 mg (1.5 ml), BZ371A 5.0 mg (1.0 ml), BZ371A 2.5 mg (0.5 ml) - Female Sexual Arousal Disorder, Female Sexual Dysfunction | Phase 2 | Recruiting | Biozeus Biopharmaceutical S.A. | 30 | 2024-10-01 | 2024-10-22 |
| Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50 Intravenous administration of Autologous, adipose-derived mesenchymal stem cells - Female Sexual Dysfunction | Phase 1 / Phase 2 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 50 | 2023-10-01 | 2026-01-22 |
| Sexual Effects of Transdermal or Vaginal Testosterone Transdermal testosterone, Vaginal testosterone gel, Placebo group - Female Sexual Dysfunction, Postmenopausal Symptoms | Phase 2 | Unknown | University of Sao Paulo General Hospital | 132 | 2020-10-01 | 2025-01-27 |
| Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment 5% sinecatechins ointment, Placebo, 10% sinecatechins ointment - Sexual Pain Disorders, Postmenopausal Symptoms | Phase 2 | Terminated | GTO Pharmaceutical, LLC | 32 | 2018-08-30 | 2022-07-27 |
| Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Testosterone undecanoate, placebo - Female Sexual Dysfunction | Phase 2 | Completed | Chulalongkorn University | 70 | 2012-06-01 | 2014-01-29 |
| Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women Syntocinon Nasalspray, Placebo Nasalspray - Female Sexual Dysfunction | Phase 2 | Completed | Medical University of Vienna | 30 | 2012-06-01 | 2014-09-01 |
| Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. PF-00446687, Placebo - Female Sexual Dysfunction | Phase 2 | Completed | Pfizer | 23 | 2007-06-01 | 2019-01-31 |
Sexual Dysfunctions, Psychological (2) · Dyspareunia (1) · Sexual Dysfunction, Physiological (1) · Vulvodynia (1)
Genital Diseases (2) · Mental Disorders (2) · Urogenital Diseases (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1) · Male Urogenital Diseases (1) · Sexual Dysfunction, Physiological (1) · Vulvar Diseases (1)
1-((1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl)carbonyl)-3,5-dimethyl-4-phenylpiperidin-4-ol (1) · Botulinum Toxins, Type A (1) · Oxytocin (1) · Petrolatum (1) · polyphenon E (1) · testosterone undecanoate (1)
Assiut University (1) · Biozeus Biopharmaceutical S.A. (1) · Chulalongkorn University (1) · GTO Pharmaceutical, LLC (1) · Medical University of Vienna (1) · Pfizer (1) · University of Sao Paulo General Hospital (1) · Vinmec Research Institute of Stem Cell and Gene Technology (1)
Brazil (2) · Austria (1) · Denmark (1) · Egypt (1) · Norway (1) · Sweden (1) · Thailand (1) · United States (1) · Vietnam (1)
Edmund C Baracat, Head (1) · Liem Thanh Nguyen, PhD (1) · Lila Nachtigall, M.D. (1) · Reuthairat Tungmunsakulchai, MD (1)